Next Article in Journal
Highlights on the Luspatercept Treatment in Thalassemia
Previous Article in Journal
CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
Previous Article in Special Issue
Juggling between the Cost and Value of New Therapies: Does Science Still Serve Patient Needs?

Article Versions Notes

Thalass. Rep. 2023, 13(1), 70-76;
Action Date Notes Link
article pdf uploaded. 16 February 2023 08:49 CET Version of Record
article xml file uploaded 17 February 2023 07:58 CET Original file -
article xml uploaded. 17 February 2023 07:58 CET Update
article pdf uploaded. 17 February 2023 07:58 CET Updated version of record
article html file updated 17 February 2023 07:59 CET Original file -
article html file updated 9 March 2023 20:16 CET Update
Back to TopTop